Sort
48,018 grants matching “immunotherapy”
Immunotherapy induced Trm arrest and reverse lung fibrosis
$409,375Maureen Renee Horton · Johns Hopkins University · R01 · FY2019 · HL
Immunotherapy induced Trm arrest and reverse lung fibrosis
$409,375Maureen Renee Horton · Johns Hopkins University · R01 · FY2020 · HL
Immunotherapy induced Trm arrest and reverse lung fibrosis
$409,375Alexander Hillel · Johns Hopkins University · R01 · FY2021 · HL
Induction of Tumor Immunity by Secreted HSP-gp96
$409,374Eckhard R Podack · University Of Miami School Of Medicine · P01 · FY2011 · CA
Immuno-Targeted Therapy for Melanoma
$409,323Antoni Ribas · University Of California Los Angeles · R35 · FY2015 · CA
B7 RECEPTORS, TUMOR IMMUNOTHERAPY AND IMMUNE REGULATION
$409,313Ohio State University · R01 · FY2002 · CA
ELUCIDATION & MODULATION OF NATURAL KILLER CELL SIGNALING: APPLICATION IN CANCER
$409,266Michael A Caligiuri · Ohio State University · P01 · FY2011 · CA
Synthetic Studies Related to Cancer Research/Treatment
$409,237Paul Wender · Stanford University · R01 · FY2024 · CA
Regulation of CD8 T Cell Immunity by CDK Inhibitor p27Kip1
$409,221Marulasiddappa Suresh · University Of Wisconsin-Madison · R01 · FY2011 · AI
Regulation of CD8 T Cell Immunity by CDK Inhibitor p27Kip1
$409,221Marulasiddappa Suresh · University Of Wisconsin-Madison · R01 · FY2012 · AI
Immunotherapy induced Trm arrest and reverse lung fibrosis
$409,218Maureen Renee Horton · Johns Hopkins University · R01 · FY2018 · HL
Enhancing anti-PD-1 blockade antitumor efficacy by oncolytic virotherapy-mediated tumor microenvironment immunomodulation
$409,158Jorge G Gomez-Gutierrez · University Of Missouri-Columbia · R21 · FY2025 · CA
INTERFERON RESISTANCE IN AFRICAN-AMERICANS WITH HCV
$409,124University Of Illinois At Chicago · R01 · FY2001 · DK
Metabolic regulation of exosome biogenesis as a determinant of cancer cell metastasis.
$409,096Marc A Antonyak · Cornell University · R01 · FY2023 · CA
Chemotherapy delivery with nanoparticles for targeted induction of immunogenic cell death
$409,064Yoon Yeo · Purdue University · R01 · FY2019 · CA
St.Louis-Cape Girardeau CCOP
$409,001St.Louis-Cape Girardeau Ccop · U10 · FY2002 · CA
REGULATION AND ADAPTIVE MECHANISMS OF ONCOGENIC RAS/ERK SIGNALING
$408,974Poulikos I Poulikakos · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
REGULATION AND ADAPTIVE MECHANISMS OF ONCOGENIC RAS/ERK SIGNALING
$408,974Poulikos I Poulikakos · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Vaccine and radiation for the therapy of human cancers
$408,968James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Harnessing the potential of pharmacological small molecules to amplify VSV-based oncolytic viral therapy
$408,966Jean Christopher Chamcheu · Southern Univ A&M Col Baton Rouge · R15 · FY2024 · CA
Mechanism of Potent Neutralization of HIV by IgA CD4i Antibody
$408,900Lisa A. Cavacini · Beth Israel Deaconess Medical Center · R01 · FY2013 · AI
Immune Profiling
$408,853Christian P Larsen · Emory University · U19 · FY2008 · AI
Engineered Ensemble Nanoimmunotherapies for Cancer
$408,831Rohan Fernandes · George Washington University · R37 · FY2021 · CA
Develop positive allosteric modulators to enhance XCR1 signaling in cancer
$408,829Cheng Zhang · University Of Pittsburgh At Pittsburgh · R21 · FY2025 · CA
Immune activation by necroptotic cell death
$408,808Andrew Atwell Oberst · University Of Washington · R01 · FY2022 · CA